GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

JATT Acquisition JATT · USD

Financials · US listing · 🇺🇸 United States

Compare

10.30

-0.39%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About JATT Acquisition

Its shares trade under the ticker JATT. It has been listed since 3 September 2021.

JATT Acquisition Corp does not have significant operations. It intends to effect a merger, capital share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company intends to focus on businesses primarily operating in the life sciences sector. JATT Acquisition Corp was incorporated in 2021 and is based in Grand Cayman, the Cayman Islands.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Financials
Industry
Capital Markets
Listed since
3 Sept 2021
Head office
C/O APPLEBY GLOBAL SERVICES (CAYMAN) LTD, GEORGE TOWN, KY1-1106
Incorporated in
E9
Classification
Blank Checks
Filer status
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • JATT Acquisition Corp focuses on life sciences sector businesses for potential mergers.
  • The company is based in Grand Cayman, a well-known financial hub.
  • Incorporated in 2021, it has a clear strategic direction for business combinations.

Weaknesses

  • JATT Acquisition Corp has no significant operations as of now.
  • The company lacks a defined business focus beyond life sciences sector mergers.
  • It has not yet completed any business combination or acquisition.

Opportunities

  • The life sciences sector offers numerous potential merger targets for JATT Acquisition Corp.
  • Grand Cayman's financial hub status supports potential business partnerships.
  • The 2021 incorporation date aligns with current market trends in financial acquisitions.

Threats

  • The lack of significant operations may deter potential merger partners.
  • The company's focus on life sciences could face sector-specific regulatory challenges.
  • No completed business combinations may lead to investor skepticism.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.